These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36478259)

  • 1. Immunohistochemical analysis of the distribution of RANKL: a case of disseminated carcinomatosis of bone marrow as the first presentation of relapse in curatively resected colorectal cancer.
    Shimada Y; Nagaba Y; Okawa H; Ehara K; Okada S; Naito M; Yokomori H
    Med Mol Morphol; 2023 Jun; 56(2):138-143. PubMed ID: 36478259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction.
    Kusumoto H; Haraguchi M; Nozuka Y; Oda Y; Tsuneyoshi M; Iguchi H
    Oncol Rep; 2006 Oct; 16(4):735-40. PubMed ID: 16969487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Carcinomatosis of Bone Marrow in an African Man with Metastatic Descending Colon Carcinoma.
    Chuwa H; Kassam NM; Wambura C; Sherman OA; Surani S
    Cureus; 2020 Apr; 12(4):e7593. PubMed ID: 32399327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.
    Vogelaar FJ; van Pelt GW; van Leeuwen AM; Willems JM; Tollenaar RA; Liefers GJ; Mesker WE
    Cell Oncol (Dordr); 2016 Dec; 39(6):537-544. PubMed ID: 27613548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of isolated disseminated carcinomatosis of bone marrow from colorectal cancer.
    Chan WK; Lin NS; Tay KV; Teo LT
    ANZ J Surg; 2023 May; 93(5):1169-1175. PubMed ID: 36772885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
    Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
    Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature.
    Takeyama H; Sakiyama T; Wakasa T; Kitani K; Inoue K; Kato H; Ueda S; Tsujie M; Fujiwara Y; Yukawa M; Ohta Y; Inoue M
    Oncol Lett; 2017 Jun; 13(6):4290-4294. PubMed ID: 28599429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
    Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
    Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
    [No Abstract]   [Full Text] [Related]  

  • 10. [A Case of Disseminated Carcinomatosis of the Bone Marrow with Carcinoma of the Rectum Diagnosed by Disseminated Intravascular Coagulation].
    Tanaka H; Matsutani S; Iwauchi T; Uchima Y; Miyamoto H; Okada T; Tsujio G; Kurihara S; Nagashima D; Hirakawa T; Hirata K; Morimoto J; Yamagata S; Takeuchi K
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2219-2221. PubMed ID: 33468913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer with disseminated carcinomatosis of the bone marrow: report of a case.
    Nakashima Y; Takeishi K; Guntani A; Tsujita E; Yoshinaga K; Matsuyama A; Hamatake M; Maeda T; Tsutsui S; Matsuda H; Fujihara M; Ishida T
    Int Surg; 2014; 99(5):518-22. PubMed ID: 25216414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma.
    Roux S; Meignin V; Quillard J; Meduri G; Guiochon-Mantel A; Fermand JP; Milgrom E; Mariette X
    Br J Haematol; 2002 Apr; 117(1):86-92. PubMed ID: 11918537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated tumour cells as a prognostic biomarker in colorectal cancer.
    Flatmark K; Borgen E; Nesland JM; Rasmussen H; Johannessen HO; Bukholm I; Rosales R; Hårklau L; Jacobsen HJ; Sandstad B; Boye K; Fodstad Ø
    Br J Cancer; 2011 Apr; 104(9):1434-9. PubMed ID: 21448171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
    Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
    Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated carcinomatosis of the bone marrow from pancreatic cancer: a case report.
    Namikawa H; Takemoto Y; Makuuchi A; Kobayashi M; Kinuhata S; Morimura M; Ikebe T; Tanaka H; Shuto T
    BMC Cancer; 2016 Oct; 16(1):801. PubMed ID: 27769217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
    Koch M; Kienle P; Hinz U; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
    Ann Surg; 2005 Feb; 241(2):199-205. PubMed ID: 15650626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.
    Todenhöfer T; Hennenlotter J; Schmiedel BJ; Hohneder A; Grimm S; Kühs U; Salih HR; Bühring HJ; Fehm T; Gakis G; Blumenstock G; Aufderklamm S; Schilling D; Stenzl A; Schwentner C
    Prostate; 2013 Jan; 73(2):162-8. PubMed ID: 22715006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
    Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
    BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.